AzTrials
AzTrials

Suicidal IdeationInforMedNCT03949556

INternet-based Programmes FOR the Prevention of Suicidal Ideation in MEDical Students

A study testing Videos and/or SMS in people with Suicidal Ideation, run by Centre Hospitalier Charles Perrens, Bordeaux at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Two programmes have been built to prevent suicidal ideation; one focuses on stress management based on cognitive and behavioural principles and the other on health promotion. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Suicidal Ideation
What is being tested?
Videos and/or SMS
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
2,544 participants
Where
1 siteFrance
Study dates
1 Jul 2021to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Being registered in the fourth year of medical studies or in the first year of residency (internship), as they appear as two critical periods over medical studies
  • Being registered in the i-Share cohort
  • 18 year-old and over
  • Speaking and reading French
  • Having given an informed consent
  • Ability to understand the type, the aims and the methodology of the study
Show all 9Show fewer
  • Agreement for online clinical assessment
  • Having a mobile phone number and an e-mail address
  • To be beneficiary of a health insurance programme

Who cannot join

  • Refusing to participate
  • Protective supervision: curatorship, guardianship

Trial locations and contacts

1 site in 1 country.

MARIE TOURNIER, MD, Prof contact

05 56 56 17 71

mtournier@ch-perrens.fr

France1 site, 1 recruiting
  • Centre Hospitalier Charles PERRENS

    Bordeaux, 33076

    Marie TOURNIER, Prof, MD, 003356561771, mtournier@ch-perrens.fr

    Helen SAVARIEAU, MSc, 003356563556, hsavarieau@ch-perrens.fr

    Recruiting

Other trials in France

About this study

Official title: Internet-based Programmes for the Prevention of Suicidal Ideation in Medical Students

Two programmes have been built to prevent suicidal ideation; one focuses on stress management based on cognitive and behavioural principles and the other on health promotion.

Read the detailed description

The main objective will be assessing their respective effectiveness on suicidal ideation (at least one occurrence over a 12-month period after the end of the intervention), through a randomized controlled trial, in medical students and interns.

Being tested
Videos and/or SMS
Medical subject headings
Suicidal Ideation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Videos and/or SMSOther

    Participants assigned to one of the intervention programmes will watch videos on a website for two months then will receive SMSs for four months.

Study groups in NCT03949556
Study groupRoleWhat they receive
Intervention program - stress management programExperimentalThis intervention program on stress management is developed to prevent suicidal ideation in medical students and residents.
Receives: Other: Videos and/or SMS
Intervention program - health promotion programActive comparatorThis intervention program on health promotion is developed to prevent suicidal ideation in medical students and residents.
Receives: Other: Videos and/or SMS
Control condition - general informationPlacebo comparatorParticipants will receive weekly emails and SMSs, over the same periods of time, with general information about health except mental health, e.g. prevention of melanoma, dental care….
Receives: Other: Videos and/or SMS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Suicidal ideation observed at least at one of the three assessment contacts (6, 12, 18 months).

    The electronic Columbia-Suicide Severity Rating Scale (e-CSSRS) will be used to investigate suicide ideation \& behaviors.

    Questionnaire was developped with NIMH support to screen \& quantify suicide risk using consecutive questions. No score is computed when using this scale.

    Questionnaire investigates suicide ideation using several questions (response yes/no):

    1. Have you wish you were dead?
    2. Have you actually had any thought of killing yourself? If 1 and/or 2 are answered "yes", 4 other questions are asked. For this study, suicide ideation will be considered as a "yes" answered to question 1 or 2.

    Measured: 18 months

Secondary outcomes (1)
  1. Suicidal behaviour identified at least once after the intervention.

    The electronic Columbia-Suicide Severity Rating Scale (e-CSSRS) will be used to investigate suicide ideation and behaviors.

    This questionnaire was developped with NIMH support to screen and quantify suicide risk using consecutive questions. No score is computed when using this scale.

    The questionnaire investigates also suicide behaviours using questions (response yes/no) on

    • actual attempt (have you made a suicide attempt? Have you done anything to harm yourself? have you done anything dangerous where you could have died?)
    • interrupted attempt
    • aborted or self-interrupted attempt
    • preparatory acts or behavior

    For the present study, suicide behavior will be considered as a "yes" to any of these 4 questions.

    Measured: 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 May 2019
  2. Study start1 Jul 2021
  3. Primary completion30 Sep 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
An open three-arm randomized controlled trial will be conducted to assess the effectiveness of two programmes of suicide prevention in fourth-year medical students and first-year interns; one based on stress management using cognitive and behavioural principles and the other on health promotion. Their respective effectiveness will be compared with a control condition. Participants will be assessed using validated questionnaires online at inclusion (before intervention) and at 6 (end of the intervention), 12, and 18 months.
Masking
None (open label)
Enrolment
2,544 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03949556
Sponsor's protocol ID
InforMed
Acronym
InforMed
Status last verified
Jun 2024
First submitted
13 May 2019
Last updated
18 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Videos and/or SMS in people with Suicidal Ideation, run by Centre Hospitalier Charles Perrens, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact MARIE TOURNIER, MD, Prof (05 56 56 17 71, mtournier@ch-perrens.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Suicidal ideation observed at least at one of the three assessment contacts (6, 12, 18 months). (time frame: 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in